Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$737K
Net Open-Market Flow
-$737K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 11, 2024Sell(S)50K$7.11$356K345K
Jul 10, 2024Sell(S)50K$6.83$342K395K
Jul 9, 2024Sell(S)6K$6.66$40K445K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019504) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about ELYM insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-24-019504"
Ask your agent
Use Arkolith to summarize insider buying and selling at Eliem Therapeutics, Inc.
over the last 90 days and cite the filings.